23andMe
hundreds of distinct clinical phenotypes across major and rare diseases a | 23andMe
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
32 of 57
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Presentation
August 2022
hundreds of distinct clinical phenotypes across major and rare diseases | 23andMe
Investor Presentation
February 2022
hundreds of distinct clinical phenotypes across major and rare diseases i | 23andMe
Investor Day
January 2022
| 23andMe
Related slides by other companies
AstraZeneca
Investor Day
September 2022
rare disease be | AstraZeneca
argenx SE
Investor Presentation
June 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
Sema4
SPAC
August 2021
oncology rare disease enabled by our disease agnostic approach diabetes cardiovascular dues | Sema4
DICE Therapeutics
Investor Presentation
March 2023
clinical response maintained in patients with higher disease burden | DICE Therapeutics
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
August 2022
Investor Presentation
February 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights